Aquaculture Vaccine Market Analysis And Forecast To 2031: By Type of Vaccines (Inactivated Vaccines, Live Vaccines), By Species (Salmon, Trout, Tilapia), By Application (Bacterial Infection, Viral Infection), By Route of Administration (Immersion Vaccines

Aquaculture Vaccine Market Analysis And Forecast To 2031: By Type of Vaccines (Inactivated Vaccines, Live Vaccines), By Species (Salmon, Trout, Tilapia), By Application (Bacterial Infection, Viral Infection), By Route of Administration (Immersion Vaccines, Injection Vaccines), And Region

The global Aquaculture Vaccine Market was valued at USD 201.5 million in 2021 and it is anticipated to grow up to USD 320.3 million by 2031, at a CAGR of 4.7% during the forecast period.

Aquaculture vaccines are vaccines that are used to protect fish, shellfish, and other aquatic animals from disease. Aquaculture is the farming of aquatic animals, and it is a growing industry worldwide. Aquaculture vaccines are used to prevent diseases that can decimate entire stocks of fish or shellfish, and they are an important tool for protecting the health of these animals. Aquaculture vaccines are typically administered via injection or immersion. Injection is the most common method of vaccination, and it is typically done with a needle and syringe. Immersion is a less common method, and it involves placing the fish or shellfish in a tank of water that contains the vaccine. Aquaculture vaccines are typically made from inactivated or attenuated (weakened) viruses, bacteria, or other pathogens.
Global Aquaculture Vaccine Market Scope and Report Structure

Market Trends and Drivers
Vaccination of farmed fish has significant benefits in combating viral and bacterial diseases with absence of undesirable side-effects of antibiotics. Also, overuse of antibiotics leads to development of resistance that ultimately leads to loss of aquaculture produce and significant economic losses. Currently, countries in Europe such as Norway have virtually stopped use of antibiotics in aquaculture practices. This has positively influenced the aquaculture vaccines market growth and lowering the risk of antibiotic resistance. Moreover, with introduction of DNA and subunit vaccines due to technological advancements, the adoption of aquaculture vaccines will increase as compared to antibiotics.
Market Restraints and Challenges
Stringent regulatory policies for manufacturing and approval of aquaculture vaccines is one of the major growth impending factors. Majority of countries have their own regulatory processes and agencies for aquaculture vaccine products approval. Also, multiple approvals are required for commercialization of aquaculture vaccines. However, long and tedious approval process by the U.S. FDA and European Union will act as the major entry barrier for new vaccines and put additional restrain on current market players.
Global Aquaculture Vaccine Market Segmental Overview
The report analyses the global Aquaculture Vaccine Market based on Type of Vaccine, Species, Infections, Route of Administration, Distribution Channel, and Region

Global Aquaculture Vaccine Market by Type of Vaccine

Based on the product type, the Aquaculture Healthcare industry is bifurcated into inactivated vaccines, live vaccines, and others. Of these, the inactivated vaccines segment registered significant revenue in 2021. The inactivated vaccines produce strong immune responses by retaining inactivated genomic component and the virus surface exposed antigens are important for strong immune response. Moreover, inactivated vaccine does not persist in the vaccinated fish or within the environment, thus they are safe in nature, thereby fostering the demand.

Global Aquaculture Vaccine Market by Species

Based on species, market is segmented into salmon, trout, tilapia, and others. The salmon segment dominated overall market share in 2021. Factors such as growing demand for salmon products along with increasing need for protection against viral and bacterial infections will augment the aquaculture vaccines market growth for salmons. Also, ban on sales of antibiotics for aquaculture will positively drive demand. Additionally, growing demand for fish protein will add more pressure on the wild fish reserve, thus leading to business expansion. Various technological advances and innovations will lead to high adoption rate of salmon vaccines.

Global Aquaculture Vaccine Market by Application

Based on applications, the Aquaculture Healthcare industry is categorized bacterial infection, viral infection, and others. The segment bacterial infection accounted for lucrative market share in 2021. Factor such as increasing incidence of bacterial infections such as vibriosis, streptococcosis, pseudomonasis and others in various fish species. Growing prevalence of bacterial infections in aquaculture has claimed millions of fish lives, this resulted in the heavy economic losses for fish farmers as well as regional economy.

Global Aquaculture Vaccine Market by Route of Adminstration

Based on the route of administration, the industry is categorized into inactivated vaccine, live vaccine, and others. The inactivated vaccine segment accounted significant revenue share in 2021. The inactivated vaccines produce strong immune responses by retaining inactivated genomic component and the virus surface exposed antigens are important for strong immune response. Moreover, inactivated vaccine does not persist in the vaccinated fish or within the environment, thus they are safe in nature, thereby fostering the demand.
Geographical Analysis of Global Aquaculture Vaccine Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America Aquaculture Vaccine Market captured significant market share in 2021 and is poised to grow substantially during the forthcoming years. Increasing research and development investment by major players such as Zoetis Inc. and Merck & Co. is fuelling the regional industry revenue. Also, government funding for development of aquaculture vaccines will further escalate the market share. For instance, in February 2021, the Foundation for Food & Agriculture Research (FFAR) funded about USD 790,326 for seeding solutions grant to the University of Florida. This fund aimed to help develop a vaccine delivery system that will prevent the spread of tilapia lake virus and other diseases in the aquaculture industry.
Major Players in the Global Aquaculture Vaccine Market
The key players in the market Zoetis, Phibro Animal Health Corporation, Elanco, Merck & Co., Inc., KBNP, CAVAC, Kyoto Biken Laboratories, Inc., Nisseiken Co., Ltd., Vaxxinova International BV, and HIPRA. among others.
COVID-19 Impact
The spread of COVID-19 pandemic across the globe has impacted the aquaculture vaccine in industry negatively in 2020. This is attributed to increasing number of COVID-19 infections along with logistical disruption in supply chains. Furthermore, decrease in the production of aquaculture vaccines owing to the reduced workforce coupled with shifting trends to develop vaccine for COVID-19 infection has influence the market growth negatively in 2020 to certain extent. However, with consecutive second and third wave of COVID-19 infections in various countries, the market is set to observe a sluggish growth in the short-term period.
Recent Developments

In October 2022, Hyderabad-based Indian Immunologicals (IIL), a subsidiary of National Dairy Development Board (NDDB), has forayed into the aquaculture health segment with the launch of its products to serve the growing need in farmed shrimp and fish in the country.
In April 2021, ICAR-CIBA has launched a recombinant vaccine against viral nervous necrosis (VNN), in a milestone for aquaculture vaccine development in India.
In September 2020, Virbac announced the acquisition of range of tilapia vaccines from Ictyogroup, an animal health company specialized in R&D biology. In addition to this acquisition, the two companies signed a partnership agreement for the development of new vaccines and new formulations for the Aqua Virbac division. This agreement is expected to avail the complete and innovative range of tilapia vaccines in Africa, Asia and Latin America. This strategy enabled company to add value to its existing portfolio and expand their customer base in untapped economies.
In January 2020, Barramundi Asia, a Singapore based company announced a merger with compatriot Allergo Aqua. The merger aimed to bring in-house fingerling R&D vaccination. This strategy helped companies to maintain long-term business relations, thereby strengthening its market presence.

Aquaculture Vaccine Market Report Coverage

The report offers a comprehensive quantitative as well as qualitative analysis of the current global Aquaculture Vaccine Market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
A thorough analysis of market trends and restraints is provided.
Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
The forecasts in this report are made by examining the recent trends along with future Aquaculture Vaccine Market potential from 2021 to 2031 in terms of revenue.
Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Aquaculture Vaccine Market are also analyzed.
Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.




Frequently Asked Questions
Q1. How big is the Aquaculture Vaccine Market?

Ans. The global Aquaculture Vaccine Market size was USD 201.5 million in 2021 and is anticipated to reach USD 320.3 million in 2031, growing at a rate of 4.7% from 2022 to 2031.

Q2. What is the Aquaculture Vaccine Market growth rate?

Ans. The growth rate of the Aquaculture Vaccine Market is 4.7%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the Aquaculture Vaccine Market in 2021.

Q4. Which segment accounted for the largest Aquaculture Vaccine Market share?

Ans. By route of administration,, the oral vaccine segment accounted for the largest Aquaculture Vaccine Market share.

Q5. Who are the key players in the Aquaculture Healthcare Market?

Ans. The global Aquaculture Vaccine Market report includes players such  Zoetis, Phibro Animal Health Corporation, Elanco, Merck & Co., Inc., KBNP, CAVAC, Kyoto Biken Laboratories, Inc., Nisseiken Co., Ltd., Vaxxinova International BV, and HIPRA. among others.

Q6. What are the factors driving the Aquaculture Vaccine Market growth?

Ans. The major factors driving the growth of the market are Growing incidence of diseases and parasites in farmed fish.

Q7. What are the key growth strategies of Aquaculture Vaccine Market players?

Ans. The key growth strategies of Aquaculture Vaccine Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Aquaculture Vaccine Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Aquaculture Vaccine Market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.